abvcpharma.com (ABVC): Prakiraan wutah bathi resik saben saham kanggo taun ngarep
In the niche natural medicine environment, ABVC BioPharma is resisting the expansion of corporate behemoths. The projected growth rate of net earnings per share demonstrates current volatility, where 0.00 is the relevant value of the indicator. The business model relies on full outsourcing of production and testing through external contractors. The company is currently scaling its line of plant-based treatments for cancer and depression.
Rincian metrik komprehensif lan analitis abvcpharma.com (ABVC)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- rincian nilai buku perusahaan:
- indikator total utang lan likuiditas perusahaan:
Rasio Total Utang marang Ekuitas ABVC BioPharma|ABVC - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal ABVC BioPharma, Inc.|ABVC - Gunggung utang perusahaan|Utang marang nilai buku ABVC BioPharma|ABVC - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan ABVC BioPharma|Rasio cepet abvcpharma.com
- informasi bathi lan kelipatan valuasi:
ABVC - Asil keuangan resik|Bathi sing dikarepake ABVC BioPharma|ABVC - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep ABVC BioPharma|ABVC - Rasio kapitalisasi marang bathi lan wutah|Pangali EV/EBITDA ABVC BioPharma|ABVC - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) ABVC BioPharma|ABVC - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan abvcpharma.com|ABVC - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep ABVC BioPharma
Analisis komprehensif perusahaan:ABVC BioPharma Inc
For long-term investors, this indicator serves as a leading signal for assessing operational efficiency and the risks of failing to meet targets. The metric measures the expected percentage change in earnings per share for the coming year, reflecting the professional community's consensus forecast. By analyzing forward EPS dynamics, one can evaluate how the success of ABVC BioPharma (ABVC) oncology drug clinical trials will impact the business's future capitalization.
Analisis pesaing ABVC BioPharma
HLN (Haleon Group) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Kenvue Health KVUE|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Verona Pharma plc (VRNA)|MENS (jyongbio.com) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep LGND (Ligand)|Prakiraan wutah bathi kanggo taun ngarep Amneal Pharmaceuticals, Inc. AMRX|Perrigo Company - Prakiraan wutah bathi kanggo taun ngarep|ALVO: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|LQDA (Liquidia Corporation) - Prakiraan wutah bathi saben saham kanggo taun ngarep|GLPG (glpg.com) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|ANIP (ANI Pharmaceuticals, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep MannKind Corp (MNKD)|Prakiraan wutah bathi saben saham kanggo taun ngarep AMPH (Amphastar)|PCRX (Pacira Corp) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep SPRY (ARS Pharmaceuticals)|theravance.com - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Aquestive Therapeutics, Inc. - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep scPharmaceuticals Inc. SCPH|tectonictx.com (TECX) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Tonix Pharmaceuticals Holding (TNXP)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep SXT Pharmaceuticals|Eupraxia Pharma - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep BHST|EXOZ (Invizyne Technologies) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ORMP (Oramed Pharmaceuticals Inc.)|Prakiraan wutah bathi kanggo taun ngarep Entera Bio Ltd ENTX|HYFT - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep CPIX (cumberlandpharma.com)|Quantum BioPharma (QNTM) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep FibroGen Inc|TELO (Telomir Pharma) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Rani Therapeutics Inc|Prakiraan wutah bathi kanggo taun ngarep SNYR|Prakiraan wutah bathi kanggo taun ngarep rallybio.com (RLYB)|Prakiraan wutah bathi kanggo taun ngarep LEXX (Lexaria Bioscience Corp.)|Pulmatrix Inc - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|PTHL: Prakiraan wutah bathi saben saham kanggo taun ngarep|APM: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|LYRA: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Impact BioMedical, Inc.|Prakiraan wutah bathi resik saben saham kanggo taun ngarep TNF Pharmaceuticals Inc.|cbdMD Corp - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep PRFX|CYTO (altamiratherapeutics.com) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep LIPO (Lipella Pharmaceuticals)|Prakiraan wutah bathi kanggo taun ngarep optinose.com OPTN|PIRS - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep PROC (Procaps Group)|Petros (PTPI) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Qilian International Corp|SLRN (Acelyrin, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep tffpharma.com
